Half a million asthma sufferers in the UK could benefit from a "breakthrough" drug that reduces complications caused by the common cold, it was claimed today.
Severe symptoms due to cold infections are one of the chief reasons why asthma patients end up in hospital.
A trial of the new drug, SNG001, at Southampton University, found it significantly reduced asthma symptoms during the critical first week of infection.
Treatment led to a 65% reduction in the number of patients experiencing moderate worsening of symptoms.
More top news
A wet start as rain continues to move east. It'll eventually dry up and brighten up this afternoon.
A wet start this morning but it'll dry up and brighten up this afternoon.
Rain will arrive through the early hours for a wet start to Monday. It will eventually brighten up by the afternoon.